W
Wee Shiong Lim
Researcher at Tan Tock Seng Hospital
Publications - 188
Citations - 6333
Wee Shiong Lim is an academic researcher from Tan Tock Seng Hospital. The author has contributed to research in topics: Medicine & Dementia. The author has an hindex of 27, co-authored 156 publications receiving 3683 citations. Previous affiliations of Wee Shiong Lim include University of Western Australia & National Healthcare Group.
Papers
More filters
Journal ArticleDOI
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Liang Kung Chen,Jean Woo,Prasert Assantachai,Tung Wai Auyeung,Ming Yueh Chou,Katsuya Iijima,Hak Chul Jang,Lin Kang,Miji Kim,Sunyoung Kim,Taro Kojima,Masafumi Kuzuya,Jenny S.W. Lee,Sang Yoon Lee,Wei Ju Lee,Yunhwan Lee,Chih Kuang Liang,Jae Young Lim,Wee Shiong Lim,Li Ning Peng,Ken Sugimoto,Tomoki Tanaka,Chang Won Won,Minoru Yamada,Teimei Zhang,Masahiro Akishita,Hidenori Arai +26 more
TL;DR: The Asian Working Group for Sarcopenia 2019 introduces "possible sarcopenia," defined by either low muscle strength or low physical performance only, specifically for use in primary health care or community-based health promotion, to enable earlier lifestyle interventions.
Journal ArticleDOI
The Asia-Pacific Clinical Practice Guidelines for the Management of Frailty
Elsa Dent,Christopher T. C. Lien,Wee Shiong Lim,Wei Chin Wong,Chek Hooi Wong,Tze Pin Ng,Jean Woo,Birong Dong,Shelley F. De La Vega,P J H Poi,Shahrul Bahyah Kamaruzzaman,Chang Won,Liang Kung Chen,Kenneth Rockwood,Hidenori Arai,Leocadio Rodríguez-Mañas,Li Cao,Matteo Cesari,Piu Chan,Edward M. F. Leung,Francesco Landi,Linda P. Fried,John E. Morley,Bruno Vellas,Leon Flicker +24 more
TL;DR: The recommendations provided herein are intended for use by healthcare providers in their management of older adults with frailty in the Asia Pacific region and it is proposed that regional guideline support committees be formed to help provide regular updates to these evidence-based guidelines.
Journal ArticleDOI
Omega 3 fatty acid for the prevention of cognitive decline and dementia
TL;DR: The available trials showed no benefit of omega-3 PUFA supplementation on cognitive function in cognitively healthy older people and the main reported side-effect was mild gastrointestinal problems.
Journal ArticleDOI
Omega 3 fatty acid for the prevention of cognitive decline and dementia
TL;DR: A recent review as mentioned in this paper showed that omega-3 PUFA supplementation is generally well tolerated with the most commonly reported side effect being mild gastrointestinal problems, and reported that minor adverse events were reported by fewer than 15% of participants, and reports were balanced between intervention groups.
Reference EntryDOI
Omega 3 fatty acid for the prevention of dementia
TL;DR: There is no good evidence to support the use of dietary or supplemental omega 3 PUFA for the prevention of cognitive impairment or dementia, and there are no randomized trials found in the search that met the selection criteria.